CLINICAL_TRIALS
research
· 2025-06-24
Clinical Trial Update: Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer [Phase 2, Phase 3]
Summary
This clinical trial entry describes an ongoing Phase 2/Phase 3 study evaluating electroacupuncture plus immune checkpoint inhibitors as adjuvant therapy after s…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Kong Fanming | Conditions: Non-Small Cell Lung Cancer, Electroacupuncture | Phase 2, Phase 3 | Status: RECRUITING